近日，全国高等学校智能医学工程专业第一轮规划教材主编人会议在北京召开。会议旨在推动高素质智 能医学人才培养，标志着我国智能医学工程专业教材体系规范化建设工作全面启动，具有重要的里程碑 意义。人民卫生出版社有关领导、全国高等学校智能医学工程专业第一届教材评审委员会以及教材主 编、副主编等90余位专家参会。会议的召开，为构建具有中国特色、国际水准的智能医学工程人才培养 体系奠定了坚实的知识基础，对促进人工智能与医学深度融合、服务健康中国战略具有深远影响。(中 国日报) ...

以下文章来源于体重管理三年行动 ，作者体重管理三年行动 国家卫生健康委员会主任雷海潮指出，"体重管理年"三年行动将持续深入推进。目前，影响我国居民健康的主要风险因素，正是慢性非传染性 疾病。许多慢病的发生，都与个人的生活习惯、饮食结构和运动状况密不可分，尤其是体重异常问题。 体重异常不仅容易引发高血压、糖尿病、心脑血管疾病和脂肪肝，甚至部分癌症也与之相关。因此，每个人都要切实担负起自身健康的第一责 任。 雷海潮介绍，接下来将从三大方面持续加强慢性病防控和体重管理： 一是全社会共同参与，营造有利于体重管理的社区、单位和社会环境，推动慢性病防控深入人心。 体重管理三年行动 . 响应国家"健康中国2030"战略，落实"体重管理年"三年行动，本账号发布权威资讯 二是持续加强慢性病防控和体重管理知识的宣传普及。动员各级医疗卫生机构积极传播健康知识，全面提升居民健康素养。 三是坚持防治结合，推行个性化服务。鼓励医疗卫生机构设立体重管理门诊，为有体重困扰的居民提供专业咨询和服务平台。 ▍居民体重管理核心知识（2024年） 健康体重管理指南：科学认知与终生实践 一、科学认知，预防为先 体重是反映人体营养与健康状态的核心指标， ...

Core Insights - The article highlights the emergence of new agricultural programs in Chinese universities, focusing on innovative training methods and alignment with industry needs [1][7][9]. Group 1: New Programs Introduced - Hunan Agricultural University has introduced a new program in Food Nutrition and Health, which is a four-year course leading to a Bachelor of Engineering degree, aligning closely with industry demands [1][3]. - Shandong Agricultural University has launched a new program in Agricultural Intelligent Equipment Engineering, set to enroll students in 2025, also offering a four-year Bachelor of Engineering degree [5][18]. - China Agricultural University has introduced a "Pet" undergraduate program under the Animal Science category, focusing on companion animals, with a four-year curriculum leading to a Bachelor of Agriculture degree [10][14]. Group 2: Industry Alignment and Demand - The new programs are designed to meet the significant demand in the "big health" industry, focusing on food nutrition, health data analysis, and dietary balance [3][12]. - The pet industry is rapidly growing, with a market size exceeding 300 billion yuan in 2024, creating a high demand for talent in pet-related fields [16][17]. - The Agricultural Intelligent Equipment Engineering program aims to address the need for skilled professionals in smart agricultural machinery, integrating advanced technologies such as IoT and automation [5][18][20]. Group 3: Educational Innovations - Universities are exploring innovative teaching methods, such as integrating artificial intelligence into agricultural education, to enhance student skills and industry readiness [9]. - Programs like the "Shennong Innovation Class" at Henan Agricultural University emphasize the importance of AI literacy in agriculture [9].

自"健康中国"理念提出以来，医疗相关产业得到重点扶持关注，到2030年，我国健康产业规模将显著扩大，总规模将达16万亿元。 其中，江苏省医疗产业发展态势良好，展现出强劲的发展后力。但与此同时，产业发展的制约问题依旧存在。"医"路同行，建行江 苏省分行为医疗企业的运营发展提供充沛动力。 医疗器械企业的成长之路 陪伴企业突破成长困境，开拓新格局，建行常州分行见证了江苏健裕健康医疗器械有限公司的转型发展。 视线投向该企业，曾经的棉纱瓦房早已不复存在，取而代之的是一幢幢配有洁净室的工业厂房，彰显着医疗产业"排头兵"的英姿。车间里，高效先进的自动 化装配线、注塑机及挤出机等设备配合默契。2019年，企业开始生产医疗领域必不可少的口罩、防护服、酒精棉片等产品，强大的生产实力使企业成长为省 级专精特新企业、国家级高新技术企业、瞪羚企业及绿色制造名单客户。近年来，结合常州当地在微创取样和内窥镜清洁方面的产业优势，企业充分发挥自 身团队在创新方面的能力，投入到微创取样领域，以活检取样钳、取样细胞刷、取物网兜等为主要产品，同时，企业还通过与手术机器人公司的联合研发， 将自主研发的机器人引入生产线上。 新的发展机遇也带来了更多的资 ...

在第三十五个全国节能宣传周期间，新时代健康产业(集团)有限公司作为中国节能环保集团旗下大健康产业支柱企业，向公众展示了其深耕绿色产业链与创 新消费模式的实践成果。 新时代健康产业(集团)有限公司总经理张红在接受采访时表示，公司通过构建"新时优品"特许经营模式与一站式健康管理服务体系，将绿色发展理念深度融 入消费端，为消费者提供专业化、个性化的健康解决方案，成为推动绿色消费与健康消费转型升级的领军力量。 打造低风险创业平台激活绿色消费新动能 新时代健康产业集团创新推出的"新时优品"特许经营模式，以"健康管理服务中心—健康管理社区站—健康顾问"三级渠道体系为核心，构建起覆盖全国的绿 色消费网络。目前，公司已在全国设立1200余家健康管理服务中心、近1.5万家社区站，并汇聚30余万名专业健康顾问，将服务触角延伸至社区与家庭。 这一模式通过"线上+线下""产品+服务"的深度融合，为消费者提供一站式健康管理服务。健康顾问依托耳穴仪、泥灸等中医设备，为消费者定制"健康监测 —评估—干预"方案；社区站则以"家门口的健康管家"定位，提供便捷的日常健康服务。同时，"新时优品"通过特许加盟模式降低创业门槛，为合作伙伴搭 建低成本 ...

在培养方式上，各大高校也在积极探索。北京大学将人工智能应用在农业教学各个环节。河南农业大学新设神农创新班，强调人工智能素 养提升。华中农业大学开设"农业人工智能+"拔尖创新人才培养项目，加速推进人工智能与农业、大生命学科的深度交叉融合。 全国首个"宠物"本科专业来了 央视网消息：现在正是高考填报志愿的日子。记者发现，今年各大高校在涉农专业的设置上出现不少新变化，在培养方式上也呈现更多创 新特点。 今年，湖南农业大学新增了食品营养与健康专业，涵盖食品免疫学、营养与代谢调控、健康数据管理等知识模块，与产业需求对接更加紧 密。湖南农业大学教务处副处长娄敏介绍，这个专业是响应"健康中国"国家战略，面向人民生命健康重大需求设立的新兴交叉学科，聚焦食品 营养与人体健康、膳食平衡调控、功能成分开发及健康大数据分析等"大健康"产业关键领域。 山东农业大学农业智能装备工程专业是今年新设置的，2025年起首次对外招生，修业年限四年，授予工学学士学位。山东农业大学机电学 院副院长宋占华表示，当前国家农业正处于转型升级阶段，农业现代化发展需求大量的智能农机装备，这一产业的市场前景广阔。各地农机企 业、科研院所等都在加大力度引进农业智 ...

Summary of Innovent Biologics Update / Briefing Company Overview - **Company**: Innovent Biologics (01801) - **Event**: Healthy China 2030 Oncology Innovation Summit and R&D Day - **Date**: June 27, 2025 Key Points Industry Context - The oncology sector is a major health threat globally, affecting individuals regardless of socioeconomic status [10][14] - The biomedicine industry in China has evolved significantly over the past decade, transitioning from generics to innovative biologics [15][20] Company Achievements - Innovent was established in 2011 and has launched 16 products, with over 20 in R&D [21][22] - The company has invested over ¥8 billion (approximately $1.2 billion) and holds 20% of China's total biologics production capacity [21][22] - In 2024, Innovent's total revenue exceeded ¥9.4 billion (approximately $1.4 billion) [24] Market Position - Innovent is a leader in several oncology segments, including PD-1, VEGF, and CD20, with three of the top ten oncology drugs in China coming from Innovent [24] - The company has made significant strides in drug accessibility and affordability, with prices for monoclonal antibodies now a fraction of those in the U.S. [17][18] Future Outlook - By 2027, Innovent aims to achieve product revenue of ¥20 billion (approximately $3 billion) and to be among the top five in sales revenue in China's biopharma sector [26][40] - The company plans to have five assets in global MRCT Phase III trials by 2030 [30][41] R&D Innovations - Innovent is focusing on next-generation technologies, including new generation immuno-oncology (IO) and antibody-drug conjugates (ADC) [32][37] - The company is developing IBI-363, a PD-1 IL-2 fusion protein, which shows promise in enhancing anti-tumor immunity [36] - Collaborations with multinational firms like Roche, Eli Lilly, and Sanofi are ongoing to enhance R&D capabilities [21][22] Challenges and Opportunities - Despite progress, there are still unmet clinical needs in oncology, and Innovent aims to address these through innovative therapies [47][49] - The company is optimistic about the potential of ADCs combined with IO therapies to improve treatment outcomes for lung cancer and other malignancies [93][94] Conclusion - Innovent Biologics is positioned as a key player in the Chinese biopharma landscape, with a strong focus on innovation and collaboration to drive future growth in oncology treatments [49][50]

21世纪经济报道记者韩利明上海报道 北京大学人民医院纪立农教授向21世纪经济报道等解释，"玛仕度肽是全球首个且唯一获批超重和肥胖 适应证的GCG/GLP-1双受体激动减重药物，其创新性结构修饰，将半衰期延长为10天。同时，玛仕度 肽独特的GCG靶点，促进脂肪燃烧，带来'燃脂护肝'直接获益。" 临床研究表明，使用玛仕度肽体重降幅达21%，降低肝脏脂肪含量超80%，腰围减少达11cm，颈围减少 达3cm，兼顾改善血糖、血压、血脂、血尿酸和转氨酶水平等心血管及代谢指标，带来全面获益。 当前，随着玛仕度肽获批上市，也意味着GLP-1赛道竞争进一步加剧，未来GLP-1的竞争将"卷"向何 处？5亿肥胖人群市场：玛仕度肽的定价与产能突围 根据中国诊断标准(肥胖：BMI≥28kg/m2；超重：BMI≥24kg/m2且＜28kg/m2)，中国约有5亿成人超重或 肥胖，全球排名第一。并且，近九成肥胖患者伴有一种以上合并症，接近50%的超重成人和超过80%的 肥胖成人患者最常见合并症为代谢性脂肪性肝病。 世界肥胖联盟(WOF)估计，2020年，中国的GDP因超重和肥胖导致的直接和间接损失可达2833亿美元左 右。因此，肥胖及相关慢 ...

中新网上海6月26日电正在上海出席第十五届中国国际健康产品展览会的Homart澳大利亚活曼特集团创 始人兼首席执行官叶蓓玲表示，该集团一直视中国为亚太地区重要战略市场，正在持续加大对中国市场 的投入。 6月24日至26日，Homart集团作为澳大利亚保健品协会(CMA)展馆代表，亮相在国家会展中心(上海)举 办的第十五届中国国际健康产品展览会，并参与展会期间的多项专业交流与对接活动，展示澳大利亚在 健康产品领域的最新成果，推动中澳健康产业深化合作。 此届展会是亚太地区较具影响力的健康营养产业平台，吸引来自全球的企业及专业人士参展。Homart 澳大利亚活曼特集团创始人兼首席执行官叶蓓玲女士受邀出席CMA展馆开幕仪式，并与澳大利亚保健 品协会主席、澳驻沪总领馆副总领事等嘉宾共同参与剪彩並代表致辞。 叶蓓玲表示，中国一直是Homart在亚太地区的重要战略市场之一。近年来，集团持续加大收购澳新具 有历史的知名品牌以及在中国市场的投入。通过跨境电商、一般贸易等渠道拓展销售网络，目前相关产 品已进入全国多地药房、母婴及零售终端，并取得5个海外保健品蓝帽和8个宠物健康产品的合规大貿进 口资质。 （文章来源：中国新闻网） ...

Group 1: Industry Overview - The domestic dairy industry is transitioning from liquid to solid products, with current per capita cheese consumption remaining low, indicating significant growth potential [1] - The "Healthy China" policy and weight management needs are driving demand for high-quality protein and dairy fat, further enhancing cheese's role as a natural nutritional carrier [1] - The penetration rate of cheese in Western cuisine, tea and coffee, and baking is continuously increasing, with chain brands frequently using products like mozzarella, cheese sauce, mascarpone, and butter, which is educating consumers and boosting demand [1] Group 2: Market Opportunities - The synergy between B-end (business) and C-end (consumer) demand is expected to create a phenomenon-level product, propelling solid dairy products towards a trillion-level market segment [1] - The ongoing research by industry associations regarding the implementation of cheese policies in schools suggests a trend towards "high-protein dairy products in schools," which could create structural opportunities for cheese in student meals [1] Group 3: E-commerce Strategy - The company is integrating Mengniu cheese for online dual-brand layout and optimizing operations on traditional e-commerce platforms like JD, Tmall, and Pinduoduo, while also expanding into interest e-commerce platforms like Douyin and Kuaishou [2] - In 2024, the company's online sales reached 378 million yuan with a gross margin of 41.56%, and the company plans to continue enhancing collaborations with major platforms [2] - During the "618" shopping festival, the company's e-commerce business performed exceptionally well, ranking first in the cheese/dairy category across all platforms, with strong sales of new products [2] Group 4: IP Cooperation - The company signed an IP rights usage service contract with its controlling shareholder, Mengniu, committing to a total of 52 million yuan in pre-tax expenses from 2025 to 2027 for diverse IP cooperation and brand marketing activities [3] - The collaboration aims to leverage marketing planning, media investment, and consulting services from the controlling shareholder to enhance brand exposure and consumer recognition [3] - The company plans to improve the efficiency of sales expenses while maintaining overall scale stability, focusing on enhancing promotional effectiveness [3]